Award
Delivery Order #SPE2D326F256H
DLA Orders Solu-Medrol Vials from Pfizer
Buyer
Defense Logistics Agency
Award Amount
$628.96
Ceiling
$628.96
Awarded
July 13, 2026
Period of Performance
Jul 13, 2026 – Jul 14, 2026
Identifier
SPE2D326F256H
NAICS
325412
This delivery order under a Defense Logistics Agency (DLA) indefinite-delivery contract directs Pfizer Inc. to supply Solu-Medrol 125 mg vials, an injectable corticosteroid medicine used to treat conditions requiring inflammation control. The order supports the DLA’s procurement of pharmaceutical products for government needs, including military health readiness. Pfizer is a pharmaceutical manufacturer and distributor. The parent contract, awarded through competitive bidding, provides for pharmaceutical supply over a long-term period; the available record does not identify the competition method for this individual order. The order covers the specified medication, with performance in New York, and a very short delivery period. No solicitation details, acquisition program, subcontractor information, or related prior orders are provided.
Description
4572360695!SOLU-MEDROL 125 MG VIALS